Rifapentine
Priftin
Rifamycin Antimycobacterial
NADAC/unit
$4.8468
Active Shortage
Tier 1: 17.9%
vs. brand Priftin: Generic saves up to 52% per unit
Active Shortages
2020-03-25 Shortage reported, Sanofi-Aventis U.S. LLC
Generic Manufacturers
SANOFI AVENTIS US LLC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.